Global Analgesics Market to Grow 4.28% by 2020 - Key Vendors are Pfizer, Endo & Purdue Pharma - Research and Markets

DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Global Analgesics Market 2016-2020" report to their offering.

The report forecasts the global analgesics market to grow at a CAGR of 4.28% during the period 2016-2020.

The report has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

According to the report, a key growth driver is the rapid industrialization in China. Changes in government policies of countries are increasing the preference for OTC drugs over prescription drugs. These drugs do not require a written prescription from healthcare professionals and can be purchased directly from pharmacy stores. This is a major factor that promotes the increased use of these products and a rise in the practice of self-medication. For instance, people with pain conditions use analgesics such as acetaminophen, aspirin, ibuprofen, and diclofenac.

Further, the report states that a major factor that could hamper market growth is the growing preference for alternative therapies. Many analgesics do not show the required long-term efficacy, which leads to patients opting for non-pharmacologic treatments for pain relief. Also, patients sometimes become allergic or experience severe side-effects from drugs or deterioration of a pre-existing disease with the use of these medications.

Key vendors:

• Pfizer
• Bayer HealthCare
• Sanofi
• Endo
• Johnson & Johnson
• Purdue Pharma
  

Key Topics Covered:

PART 01: Executive summary

PART 02: Scope of the report

PART 03: Market research methodology

PART 04: Introduction

PART 05: Pipeline portfolio

PART 06: Market landscape

PART 07: Market segmentation by drug class

PART 08: Market segmentation by type

PART 09: Market segmentation by application

PART 10: Market segmentation by pain type

PART 11: Market segmentation by ROA

PART 12: Geographical segmentation

PART 13: Market drivers

PART 14: Impact of drivers

PART 15: Market challenges

PART 16: Impact of drivers and challenges

PART 17: Market trends

PART 18: Vendor landscape

PART 19: Appendix

For more information visit http://www.researchandmarkets.com/research/nv72zb/global_analgesics